Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Market Closed - Toronto S.E.
Other stock markets
 03:28:28 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.51 CAD -.--% Intraday chart for Satellos Bioscience Inc. +6.25% +18.60%
May. 28 Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment MT
May. 28 Satellos Bioscience Inc. Brief: Announcing Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy MT

Evolution of the average Target Price on Satellos Bioscience Inc.

Price target over the last 5 years

History of analyst recommendation changes

6738ebed.ByWQACtW_IFvQQTe2fdOiLukum3r9vi5kW7e0HrlTTE.Mk3ENXs3jcMLNHXrkJskx_bC3l7aroz-2V7mmCKyDlhvf_xKXDiatgokMA~6e52fbaadef5e12458baf94a1b396219

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.51 CAD
Average target price
1.2 CAD
Spread / Average Target
+135.29%
High Price Target
1.2 CAD
Spread / Highest target
+135.29%
Low Price Target
1.2 CAD
Spread / Lowest Target
+135.29%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Consensus Satellos Bioscience Inc.